NGS

FDA Announce New Policy on NGS

The FDA said yesterday it will relax its review of some genetic tests that examine millions of different variants at the same time, and finalised two guidances designed to enhance collaboration among researchers, and drive the efficient development of novel NGS-based tests. 

QIAGEN to Aquire STAT-Dx

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.

Stuff to Read, Week 7

Here are five stories you should read this week. The conversation with George Church is highly recommended!

2017: This Was Your Year, Part II

In part one, we relived the excitement of January – June 2017. How did the year progress through the summer stretch and into the festive period? It’s only one way to find out…

2017: This Was Your Year

Now that the Festival of Genomics London is done, dusted, and in the record books, we take a look back at what you were busy reading on our website during 2017, including your answers from our survey.